Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $64.3700 (-0.91%) ($64.1100 - $64.3700) on Tue. Aug. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.81% (three month average) | RSI | 17 | Latest Price | $64.3700(-0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XHB(76%) XBI(75%) VFMO(69%) XAR(68%) IBB(64%) | Factors Impacting LGND price | LGND will decline at least -0.905% in a week (0% probabilities). TAN(-11%) VXX(-41%) UUP(-30%) TBT(-22%) XLU(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.905% (StdDev 1.81%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $61.87(-3.88%) | Resistance Level | $66.71 | 5 Day Moving Average | $65.59(-1.86%) | 10 Day Moving Average | $66(-2.47%) | 20 Day Moving Average | $66.71(-3.51%) | To recent high | -18.5% | To recent low | 0% | Market Cap | $1.034b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |